| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.001 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.007 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.34 | 0.008 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.36 | 0.009 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.43 | 0.01 |